Hormonal Contraceptives Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Method (Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, Others), By Hormone (Combination Hormonal Contraceptives v/s Progestin Only), By Region, and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationHormonal Contraceptives Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Method (Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, Others), By Hormone (Combination Hormonal Contraceptives v/s Progestin Only), By Region, and Competition
For instance, in April 2021, the Food and Drug Administration approved a combination of drospirenone and estetrol tablet Nextstellis marketed by Mayne Pharma for preventing pregnancy, one of the first combination pills containing naturally occurring estrogen.
Increasing Number of Unplanned Pregnancies
As per a publication in PubMed, the number of unintended pregnancies in the U.S are around three million annually.
Development of New Contraceptives
According to the United Nations Contraceptive Use by Method, 2019 study, a single method accounts for 50% or more of all contraceptive use in at least one out of every five nations or regions.
Recent Development
- For instance, in April 2021, Mayne Pharma received U.S. FDA approval for NEXTSTELLIS and estetrol for avoiding pregnancy. It is the only contraceptive pill with E4 and a plant-based estrogen having few important benefits compared to other estrogens.
- For instance, in July 2021, the MHRA launched the OTC sale of contraceptive pills in U.K. pharmacies. Two contraceptive pill brands, Hana and Lovima, are selling desogestrel- synthetic progesterone, OTC with a brief consultation with a pharmacist.
- For instance, in June 2021, Teva Pharmaceuticals USA launched the generic form of NuvaRing, Ethinyl estradiol, and etonogestrel vaginal ring contraceptive.
- In February 2020, Agile Therapeutics, Inc. received U.S. FDA approval for the Twirla, a transdermal patch containing levonorgestrel and Ethinylestradiol.
- In recent years, several new hormonal contraceptives have been approved by regulatory agencies around the world. For example, in 2019, the US FDA approved Annovera, a new vaginal ring that can be used for a year, and in 2021, the FDA approved Phexxi, a non-hormonal contraceptive gel that can be used before sex. These new products offer women additional options for birth control and are likely to drive market growth.
- As the demand for hormonal contraceptives grows in developing markets, several companies are expanding their operations to these regions. For example, in 2020, Merck announced plans to invest $500 million to expand its manufacturing operations in Asia and Africa. This move is expected to increase access to hormonal contraceptives in these regions and drive market growth.
- Twirla is a new hormonal contraceptive patch that was approved by the US FDA in 2020. It contains the hormones progesterone and estrogen and is worn on the skin for a week at a time. It is a new option for women who prefer a non-pill form of hormonal contraception.
- Sayana Press is an injectable contraceptive that was launched by Pfizer in 2019. It contains the hormone progestin and is administered subcutaneously. It is a more user-friendly and convenient option for women who want a longer-acting form of birth control.
Market Segmentation
The global hormonal contraceptives market can be segmented by method, by hormone and by region. Based on method, the market can be segmented into Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, Others. Based on hormone, the market can be divided into Combination Hormonal Contraceptives v/s Progestin Only. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global hormonal contraceptives market on account of increasing unplanned pregnancies with low-cost product in the country.
Market Players
Abbvie, Inc., Afaxys, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Merck & Co. Inc., Organon Group of Companies, Pfizer Inc., Johnson & Johnson, Lupin Pharmaceuticals Inc., Pregna International Ltd. are some of the leading players operating in the Global Hormonal Contraceptives Market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | · By Method · By Hormone · By Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Turkey; Egypt |
| Key companies profiled | Abbvie, Inc., Afaxys, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Merck & Co. Inc., Organon Group of Companies, Pfizer Inc., Johnson & Johnson, Lupin Pharmaceuticals Inc., Pregna International Ltd. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy